Suppr超能文献

使用等位基因特异性定量PCR和PCR-RFLP分析快速检测突尼斯的SARS-CoV-2变体:一种适用于发展中国家的廉价灵活方法。

Use of allele-specific qPCR and PCR-RFLP analysis for rapid detection of the SARS-CoV-2 variants in Tunisia: A cheap flexible approach adapted for developing countries.

作者信息

Ayadi Wajdi, Smaoui Fahmi, Gargouri Saba, Ferjani Sana, Hamzaoui Zaineb, Taktak Awatef, Chtourou Amel, Skouri-Gargouri Houda, Sassi Azza Hadj, Sassi Mouna Ben, Trabelsi Sameh, Gargouri Ali, Boubaker Ilhem Boutiba-Ben, Karray-Hakim Héla, Mokdad-Gargouri Raja, Feki-Berrajah Lamia

机构信息

Laboratory of Molecular Biotechnology of Eukaryotes, Center of Biotechnology of Sfax, University of Sfax, Sfax, Tunisia.

Laboratory of Microbiology, Research Laboratory for Microorganisms and Human Disease LR03SP03, Habib Bourguiba University-Hospital, Sfax, Tunisia.

出版信息

PLoS One. 2025 May 5;20(5):e0321581. doi: 10.1371/journal.pone.0321581. eCollection 2025.

Abstract

Monitoring the emergence and propagation of SARS-COV2 variants, especially Omicron variants, remains a major concern in developing countries, including Tunisia. We here report lessons of simple approaches used to track prevalent Omicron variants in the city and district of Sfax, Tunisia, between June 2022 and April 2023. Initially, the screening approach was designed by selecting and verifying key SARS-CoV-2 mutations using publicly available sequencing data. Then, the analytical performance of the screening tests was rigorously assessed before being implemented on 227 confirmed COVID-19 cases. In a first stage, from June to September 2022, allele-specific (AS)-qPCR detection of deletions ΔHV69-70 (S gene) and ΔKSF141-143 (ORF1a gene) allowed identification of BA.5 as the predominant variant (128 out of 165 cases; 77.5%) which quickly replaced the pre-existing lineages BA.4 (15.7%) and BA.2 (6.7%). In a second stage, from October 2022 to April 2023, circulation of additional variants was demonstrated using concomitant detection of new relevant mutations by PCR-RFLP (n=62). Detection of mutations Y264H (ORF1b) and V445P/G446S (S gene) resulted in the identification of 38 cases of the BQ.1 variant and 14 cases of the XBB variant, respectively. Further restriction analysis of the S gene was conducted to screen more recent sublineages, including CH.1.1. For all sequenced cases (n=115), our rapid detection assays showed perfect concordance with sequencing results in identifying SARS-CoV-2 variants. These findings highlight the potential of simple, cheap and proven methods for rapid genotyping and monitoring of SARS-COV2 variants. Therefore, these methods appear as valuable tools for effective infection control and prevention in developing countries.

摘要

监测严重急性呼吸综合征冠状病毒2(SARS-CoV-2)变体,尤其是奥密克戎变体的出现和传播,仍然是包括突尼斯在内的发展中国家的一个主要关切问题。我们在此报告2022年6月至2023年4月期间在突尼斯斯法克斯市及行政区追踪流行奥密克戎变体所采用的简单方法的经验教训。最初,通过使用公开可用的测序数据选择并验证关键的SARS-CoV-2突变来设计筛查方法。然后,在对227例确诊的新冠肺炎病例实施之前,对筛查试验的分析性能进行了严格评估。在第一阶段,2022年6月至9月,通过等位基因特异性(AS)-qPCR检测缺失ΔHV69-70(S基因)和ΔKSF141-143(ORF1a基因),确定BA.5为主要变体(165例中的128例;77.5%),其迅速取代了先前存在的谱系BA.4(15.7%)和BA.2(6.7%)。在第二阶段,2022年10月至2023年4月,通过PCR-RFLP同时检测新的相关突变,证明了其他变体的传播(n = 62)。检测到Y264H(ORF1b)和V445P/G446S(S基因)突变,分别确定了38例BQ.1变体病例和14例XBB变体病例。对S基因进行了进一步的限制性分析,以筛查更新的亚谱系,包括CH.1.1。对于所有测序病例(n = 115),我们的快速检测方法在鉴定SARS-CoV-2变体方面与测序结果显示出完美的一致性。这些发现突出了简单、廉价且经过验证的方法在快速基因分型和监测SARS-CoV-2变体方面的潜力。因此,这些方法似乎是发展中国家有效控制和预防感染的有价值工具。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8be1/12052121/3460fa2d3c06/pone.0321581.g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验